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Elucidation of the mechanism by which
OIS is overcome in melanomas arising
in these neoplasms will also be an
important step toward improved
therapeutic targeting.
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Nuclear Topology, Epigenetics, and
Keratinocyte Differentiation
Michael W. Hughes1, Wange Lu2 and Cheng-Ming Chuong1,3
Recent progress in epigenetics reveals dynamic chromatin interactions in the
nucleus during development, regeneration, reprogramming, and in disease.
Higher-order chromatin organization is manifested as changes in the topological
distribution of eu-/heterochromatin and in nuclear morphology. We are now able
to gain new knowledge about these changes at the genomic level.
Journal of Investigative Dermatology (2013) 133, 2130–2133. doi:10.1038/jid.2013.261
In pathology, nuclear morphology is
one of the features used to recognize
differentiated cell types as is seen in the
multilobed nuclei of neutrophils, cart-
wheel-shaped nuclei in plasma cells,
and large round nuclei in lymphocytes.
Mature skin fibroblasts, ordinarily hav-
ing elongated and condensed nuclei,
begin to exhibit enlarged and ‘‘pale’’
nuclei in response to injury. Such
features reveal changes in gene expres-
sion profiles in those nuclei. With
See related article on pg 2191
progress in systems biology, we are
now on the verge of understanding the
molecular mechanisms that underly
these changes.
Every somatic cell has identical
genetic content. How can different
genes be expressed in different cell
types or in the same cell type when in
different functional states? Normal cell
behavior requires a series of coordinated
interactions between cells and their
local environments to induce specific
gene expression patterns. Global gene
expression profiles are achieved by
different epigenetic modulations of
chromatin conformation. Therefore, it
is important to understand how these
processes function during cellular
homeostasis in order to create unique
and specific therapies for disease.
Previously, our understanding of the
role of DNA conformation reflected
gene-specific phenotypes or mutations,
with epigenetic processes left as an
incomprehensible black box. Advances
in genomics and systems biology has
started to reveal the workings of this
black box, leading to a new understanding
of disease in terms of epigenetic
processes and high-order chromatin
organization (Misteli, 2010; Lee and
Young, 2013).
In this issue, Gdula et al. (2013)
characterize the changes in nuclear
shape that take place during epidermal
keratinocyte differentiation. Briefly, the
authors show that basal keratinocytes
possess a vertically orientated,
columnar-shaped nucleus that
gradually becomes a horizontally
shaped spheroid in the uppermost
supra-basal layers. Here we use this
paper as a lead-in (or beacon) to
introduce exemplary papers that
report the epigenetic processes
during keratinocyte differentiation. A
special issue in Cell (14 March 2013)
covers the topic of nuclear dynamics
and includes several up-to-date
reviews for those who wish to
explore this important area further.
Epigenetic processes during development,
reprogramming, and disease
DNA is the blueprint for coordinated
gene expression, resulting in a multitude
of biological processes. The ability to
attain spatiotemporal gene expression
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patterns requires specific nuclear packa-
ging that permits dynamic transcription
machinery accessibility. Different regions
of DNA exist primarily in two chro-
matin packaging states: a more open
conformation termed euchromatin and
a more closed conformation termed
heterochromatin. However, this situa-
tion is fluid, with various DNA regions
changing chromatin status dynamically
to coordinate gene expression programs.
Therefore, gene promoters separated
by large distances, sometimes located
on different chromosomes, are able to
interact physically through chromatin
remodeling.
Nucleosomes are enwrapped by
147 bp of DNA to package a tremen-
dous amount of material efficiently into
very small spaces. This is modulated by
histone proteins whose tails can be
modified chemically in several different
ways (methylated, acetylated, phos-
phorylated, sumoylated, and ubiquiti-
nated) at specific amino acid positions
to control gene expression (Bannister
and Kouzarides, 2011). For example,
histone methylation occurs on lysine
residues as mono-, di-, or tri-methyl
modifications and is associated with
gene suppression and a closed chromatin
conformation as seen in H3K9me1,
H3K9me2, and H3K9me3. Histone
acetylation occurs on lysine residues
and can be associated with an open
chromatin conformation, enabling gene
expression as seen in H3K9Ac. Histone
phosphorylation occurs on serine
residues and is associated with
interphase gene expression as seen in
H3S10P. Histone sumoylation occurs
on lysine residues and is associated
with transcriptional repression as seen in
H2BK6Su. Histone ubiquitination occurs
on lysine residues and is associated
with maintaining chromatin domain
boundaries as seen in H2BK120Ub.
Thus, the chromatin landscape can
change dynamically depending on the
histone modification present at specific
amino acids. The collection of histone
modification patterns in the nucleosome
has been proposed to serve as histone
codes in the modulation of gene
expression by epigenetic mechanisms
(Suva et al., 2013).
Why is three-dimensional (3D) nuclear
compartmentalization important (Gdula
et al., 2013)? It is important because it is
a window into the role of developmental
programming in cellular competency.
In development, basal keratinocytes
respond very differently than do supra-
basal keratinocytes to stimulation by
specific growth factors. Cellular compe-
tency depends on the histone codes that
a cell possesses. In a simplified way,
histone modification status can be
inferred by observing changes in chro-
matin configuration and nuclear shape.
For a more complete understanding,
one must apply the so-called ‘‘omics’’
systems biology approaches. However,
these biochemical analyses require a
large number of cells. Although this
approach has been used in studies with
cultured or sorted stem cells, its applica-
tion to heterogeneous tissue specimens
(such as skin) has been difficult, and
await procedures that use fewer cells.
Endogenous and/or exogenous factors
have been shown to regulate the epige-
netic modifications that reprogram cells
and reset developmental competency.
For example, differentiated adult skin
fibroblasts or keratinocytes can be
induced to regain multipotency or pluri-
potency by reprogramming with forced
expression of exogenous factors, which
act to reset the epigenetic landscape and
chromatin status. On the other hand,
endogenous reprogramming has been
found to occur during large wound–
induced follicular neogenesis in the
mouse. Local basal keratinocytes migrate
into the center of the wound bed and
become competent to form new hair (Ito
et al., 2007). Interestingly, a similar
phenomenon has been shown recently
in African spiny mice, which use skin
autotomy to escape from predators, but
which can readily regenerate skin
that includes hairs (Seifert et al., 2012).
Cells in the regenerating skin are
reprogrammed by endogenous factors
produced by the wound, although they
have yet to be identified.
Nuclear architecture is important for
cellular function. Mutations of several
chromatin looping proteins have been
linked to human diseases (Misteli,
2010). For example, the zinc-finger
protein CCCTC-binding factor (CTCF)
is a global chromatin organizer, and
loss of the CTCF-binding site at the
p16 tumor-suppressor locus can lead to
cancer. Cohesin is facilitated by a
multiprotein complex that can colocalize
with CTCF in insulator regions. Loss of
cohesin can lead to loss of boun-
daries at heterochromatin regions and
cause postnatal developmental dis-
orders. Lamin A is responsible for
heterochromatin stability at the peri-
phery of the nucleus. Mutations of
Lamin A can result in premature aging.
(Dechat et al., 2010)
Epigenetic processes in keratinocyte
differentiation
Recently, more epigenetic studies have
been carried out in the context of skin
biology (reviewed in Botchkarev et al.
(2012)). In this issue, Gdula et al. (2013)
investigate nuclear topology in epidermal
keratinocytes as they differentiate from
the basal to the supra-basal layer. 3D
confocal microscopy data demonstrated
nuclear shape changes as keratinocytes
differentiated terminally, suggesting that
chromatin was compacted dynamically
during this process. Not surprisingly,
the nuclear volume was reduced as
cells differentiated into a squamous
epithelium. Immunohistochemistry was
used to characterize chromatin dis-
tribution in the keratinocyte layers. The
basal and spinous layers exhibited the
highest levels of markers for active gene
expression: phosphorylated RNA Pol II,
H3K4me3, and H3K56Ac. These levels
were significantly lower in the granular
Clinical Implications
 Keratinocyte progenitors differentiate into different phenotypes via epi-
genetic changes. Manifestation of nuclear morphology change is a
window to these dynamic chromatin re-organizations.
 Several diseases show characteristic abnormal nuclear architecture.
 Changes in nuclear structure, defined at the molecular level, may be used
as a disease marker and to help understand molecular pathogenesis.
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layer. In addition, nucleoli were redu-
ced in number and migrated toward
the center of the nucleus as termi-
nal differentiation progressed. Hetero-
chromatin domains were characterized
by 3D fluorescent in situ hybridization
(3D-FISH) combined with immuno-
fluorescence staining. The volume of
nucleolar domains increased signifi-
cantly in the supra-basal layers when
compared with the basal layer. Simul-
taneously, peri-centromeric hetero-
chromatin clusters increased in the
supra-basal layers.
Taken together, this paper illustrates
spatiotemporal dynamics in nuclear
topology during keratinocyte dif-
ferentiation. It correlates morphological
changes of nuclei with gene expression,
gene transcription machinery localiza-
tion, topology of histone modifications,
and nucleoli morphology. This work
does not rely solely on correlations,
and it advances our understanding of
this field significantly.
In another recent paper, this group
used a combination of 3D-FISH, immu-
nohistochemistry, and gene expression
analysis to demonstrate the dynamic
interaction of Rps2, Lor, and Gabpb2
in the epidermis of p63 / and
Satb1 / mice (Fessing et al., 2011).
Perturbation of either p63 or Satb1
altered skin development and barrier
formation. Interestingly, overexpression
of Satb1 partially rescued the p63 /
phenotype. The investigators demon-
strated further that p63 regulates Satb1
in chromatin remodeling, and they
showed elegantly how chromatin com-
paction patterns, transcription factors,
and gene clusters work together to
modulate cellular fate.
Enzymes involved in modifying his-
tones are important for normal epi-
genetic processes. Their critical role in
keratinocyte differentiation is demon-
strated by several examples. The histone
methyltransferase EZH1/2 modulates
H3K27 methylation for proper hair
follicle homeostasis and wound healing
by supporting bulge stem cell survival
(Ezhkova et al., 2011). The histone
deacetylases HDAC1/HDAC2 are
required for skin development in the
mouse embryo (LeBoeuf et al., 2010).
Mice with K14-mediated suppression
of DNMT1 exhibit normal-appearing
hair but progress to alopecia, because
the ability of hair bulge stem cells to
regenerate declines as mice age (Li
et al., 2012).
There are additional studies highlighting
the significance of nuclear morphology
and topology in skin biology. Ichthyosis
vulgaris etiology is a mutation in the
filaggrin gene, and these cells, among
several phenotypic alterations, exhibit
large nuclei and changes in cell shape
(Irvine et al., 2011). Long noncoding
RNAs (lncRNAs) represent another
mechanism for modulating topological
compartmentalization of nuclei. They
bring together gene expression domains,
and they can recruit chromatin modi-
fiers such as the Polycomb Repression
Complex. This, in turn, leads to histone
tail modifications, resulting in chromatin
compaction pattern changes that deli-
neate chromatin domains (Batista and
Chang, 2013). Recently, an lncRNA,
terminal differentiation–induced ncRNA,
was shown to control human epidermal
differentiation (Kretz et al., 2013).
Functional topology of nuclear
complexity has begun to be revealed by
new technology
Thus, the nucleus is organized spatio-
temporally at different levels: DNA
sequences coding for specific genes,
nuclear DNA packaging into chromatin
domains, and higher-level organization
with the arrangement of chromatin
into chromosomal territories including
eu- and heterochromatin functional
domains (Cremer and Cremer, 2010).
Microscopic imaging techniques using
in vivo time lapse and confocal 3D
image visualization, together with next-
generation sequencing and chromosome
conformation capture, contribute a
higher-resolution picture of how the
various nuclear compartments are org-
anized. 3D reconstruction of con-
focal Z Stack data permits visualization
of nuclear compartments and the asso-
ciated epigenetic marks during cellular
reprogramming (Hajkova et al., 2008).
Chromosome conformation capture (3C,
4C, and 5C) techniques have elucidated
long-distance chromosomal region
interactions. Collectively, this pro-
gress has permitted a more global view
of long-range chromatin domain inter-
actions.
This is an exciting time for skin biol-
ogy research. We are currently witnes-
sing the tip of the iceberg! As we get into
the core of keratinocyte differentiation,
cellular reprogramming, and epigenetic
process-based diseases, we will make
novel and fundamental discoveries per-
taining to dynamic nuclear behavior.
This new knowledge should unveil
how shared genomic DNA can be
expressed differently in multiple physio-
logical or pathological cell types. As a
result, new strategies for stem cell ther-
apy and disease diagnosis will emerge.
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PUMA: A Puzzle Piece in
Chloroquine’s Antimelanoma Activity
Ravi K. Amaravadi1
Chloroquine (CQ) can induce cell death in a subset of cancer cell lines, and some
melanoma cell lines are quite susceptible. Although it is well known that CQ
impairs lysosomal function and can serve as an autophagy inhibitor, the molecular
target of CQ and the subsequent cascade of events that lead to cell death are not
fully understood. Recent evidence indicates that in melanoma cell lines, CQ
induces apoptosis by preventing degradation of the pro-apoptotic BH3-only
protein p53-upregulated modulator of apoptosis. This finding adds to the
unfolding story of CQ’s mechanism of action as a cancer therapeutic agent.
Journal of Investigative Dermatology (2013) 133, 2133–2135. doi:10.1038/jid.2013.135
Although there is clear evidence that
chloroquine (CQ) derivatives at micro-
molar concentrations impair lysosomal
function, block autophagy, and elicit
cell death in certain cancer cells, the
molecular target of CQ derivatives and
the molecular mechanism of CQ-asso-
ciated cell death have not been fully
identified. In this issue, Lakhter et al.
2013 demonstrate a critical role for the
pro-apoptotic BH3-only protein p53-
upregulated modulator of apoptosis
(PUMA) in CQ-associated cell death in
melanoma cells (Lakhter et al., 2013).
This paper provides a provocative step
forward in connecting the dots between
CQ and apoptosis that may have sig-
nificant implications for the develop-
ment of CQ derivatives to treat
melanoma and other cancers.
A brief history of CQ’s use in human
disease
CQ is one of the most widely used and
successful human drugs in the history of
medicine. Since it was first synthesized
in 1934 and its implementation as the
first effective malaria prophylactic in
1947, it is estimated that hundreds of
millions of humans have benefited from
CQ and its derivatives (Jensen and
Mehlhorn, 2009). Once widespread
resistance emerged in malaria strains,
CQ and its better tolerated derivative
hydroxychloroquine (HCQ) were reposi-
tioned to treat rheumatic diseases (Katz
and Russell, 2011). HCQ has been
tested in clinical trials as an anti-
coagulant because of its functional
effects on platelet aggregation(Carter
and Eban, 1974), as an antiviral against
See related article on pg 2247
HIV (Paton et al., 2012), and as an
immunosuppressant for graft-versus-host
disease (Khoury et al., 2003). With the
exception of malaria and rheumatic
disorders, where low doses of HCQ
provide clinical benefit, randomized
trials proved that a standard dose of
HCQ provided no benefit as an anti-
coagulant, antiviral, or immunosuppres-
sive agent, despite strong preclinical
data supporting its utility for these
indications. Possible explanations for
the lack of efficacy in late-stage trials
include the lack of a dose escalation
component to earlier phase studies and
lack of mechanism-based pharmaco-
dynamic end points that would deter-
mine whether the relevant molecular
targets had been affected.
More recently, higher doses of CQ
derivatives have been tested as antic-
ancer agents. Initial studies in cancer
capitalized on the knowledge that CQ
derivatives accumulate within and
impair lysosomal function, likely block-
ing multiple cellular processes, includ-
ing autophagy. Autophagy is a multistep
catabolic process that consists of
sequestration of damaged organelles
and proteins in autophagic vesicles,
followed by fusion with lysosomes,
leading to the degradation of autophagic
vesicle contents and recycling of sugars,
amino acids, and lipids. Although it is
clear that autophagy has pro-death and
pro-survival roles in different contexts,
there is increasing evidence that in
advanced cancer, autophagy improves
the fitness of cancer cells, as it serves
to rid the struggling cancer cells of
damaged organelles, recycle basic
building blocks, and provide an internal
source of energy. There is some evi-
dence that basal levels of autophagy are
increased in solid tumors (Lazova et al.,
2012), as they cope with the metabolic
stress of limited resources within the
tumor microenvironment and unbridled
growth fueled by oncogenes. Certain
cancers such as melanoma can have
very high levels of autophagy (Lazova
et al., 2012). Melanoma may be intrin-
sically prone to high autophagy levels,
as much of the machinery involved
in melanogenesis are components of
autophagy, rendering most melano-
cytes professionally autophagic. Cancer
therapies induce autophagy, further
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